Gonorrhea

FRANK ZAPPA'S INCREDIBLY RARE RECORDINGS, BELIEVED TO HAVE BEEN PLANNED FOR A POTENTIAL SEQUEL TO HIS ICONIC "HOT RATS" ALBUM, HAVE BEEN UNEARTHED FROM THE VAULT AND COMPILED AS NEW COLLECTION, "FUNKY NOTHINGNESS"

Retrieved on: 
Friday, April 21, 2023
Flo, Hank Ballard, Underwood, Music, Magic, Chunga's Revenge, Frank Zappa, Rollin, Mother, Chemistry, Collection, Revenge, R, WITH, Beat the Boots!, Work with Me, Don and Dewey, Travers, Hot Rats, AND, Don, The Mothers of Invention, Bernie, IAN, Sydney Nathans, Record Plant, CORE, Peaches en Regalia, Music Tribe, Procuring (prostitution), Boot, Gonorrhea, LOS, RARE, Willie the Pimp, The Wrecking Crew, Annie Had a Baby, DON, Trout Mask Replica, Aynsley Dunbar, Uncle Meat, R&B, Midnighters, Flo & Eddie, Lightnin' Slim, Mathematical optimization, Lightnin' and Co., Nightclub, Cassette tape, Weaving, L.A, FZ

Largely instrumental, these recordings showcased the guitarist's virtuosity, while offering what could have easily been the sequel to Hot Rats, had it ever been released.

Key Points: 
  • Largely instrumental, these recordings showcased the guitarist's virtuosity, while offering what could have easily been the sequel to Hot Rats, had it ever been released.
  • Flo & Eddie would join the Mothers for Zappa's Chunga's Revenge album, recorded mostly that summer and released in October of that year.
  • By the end of 1970, Zappa was well into writing and developing his film, "200 Motels" and the accompanying soundtrack.
  • It's a head-scratcher for sure, but it does make sense as Frank was embracing audio technology as soon as it became available."

Grandma, Let's Talk About Safer Sex: Jems Condoms Launches F#cking Old Campaign to Encourage Seniors to Have Conversations about STIs and Sexual Health

Retrieved on: 
Thursday, April 20, 2023
Partnership, Syphilis, Gen, Sue Johanson, STI, CSA, Culture, Parent, Taboo, Gonorrhea, Grandparent, Social media, Old, Collection, Risk, Hook-up, Chlamydia, Action Canada, Birth control, Jem (singer)

With sexually transmitted infections rising at a dangerous rate, 'F#cking Old' is encouraging younger Canadians who are comfortable in talking openly about sex, to speak with their elders about safer sex.

Key Points: 
  • With sexually transmitted infections rising at a dangerous rate, 'F#cking Old' is encouraging younger Canadians who are comfortable in talking openly about sex, to speak with their elders about safer sex.
  • To launch the campaign, Jems has partnered with Jane Johanson, daughter of globally-recognized sex expert and beloved Canadian television personality Sue Johanson, former host of the Sunday Night Sex Show.
  • "Talking about sex with your parents or grandparents may be awkward, but frankly, has never been more necessary," said Johanson.
  • F#cking Old is an extension of Jems' commitment to making sexual wellness more inclusive for all.

binx health Further Expands Commercial Team in Support of Point-of-Care National Rollout

Retrieved on: 
Monday, April 17, 2023
Male, CT, STI, Urine, Human services, Health, Gonorrhea, Centers for Disease Control and Prevention, CDC, Investment, Patient, NG, Chlamydia, United, POC, FDA, Female, Assistant Secretary of Health and Human Services for Planning and Evaluation, Birth control

The need for accurate, accessible, and timely STI testing has become more critical than ever.

Key Points: 
  • The need for accurate, accessible, and timely STI testing has become more critical than ever.
  • "The platform is easy-to-use and delivers results in about 30 minutes, which has allowed us to streamline our testing process and provide better care to our patients.
  • “Providing healthcare professionals and patients with innovative, safe and simple solutions for point-of-care STI testing is the cornerstone of our commitment,” said Todd Bennett, Chief Commercial Officer of binx health.
  • “We have attracted top industry talent providing our customers with a clear and consultative approach.

Recce Pharmaceuticals to be Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives

Retrieved on: 
Tuesday, April 11, 2023
Patent, Inhalation, Australian patent law, Veterans' Preference Act of 1944, Cytomegalovirus, HIV, EBV, SARS-CoV-2, Streptococcus pyogenes, Recce, Gonorrhea, Skin, ASX, FSE, Burn, Staphylococcus, Shingles, Escherichia coli, Severe acute respiratory syndrome outbreak, Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Simplex, Varicella zoster virus, PCT, Viral disease, Urinary tract infection, Pseudomonas aeruginosa, Administration, Neisseria meningitidis, Patient, Biology, Ross River virus, Viral, Infection, Bacteria, Virus, HCMV, Disease, RCE, Pharmaceutical industry, Vaccine, Proteus, Serratia, Enterococcus

SYDNEY, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the Australian Patent Office issued notification of intent to grant Recce a new family four patent, “Process for Preparation of Biologically Active Copolymer,” with expiry in 2041.

Key Points: 
  • SYDNEY, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the Australian Patent Office issued notification of intent to grant Recce a new family four patent, “Process for Preparation of Biologically Active Copolymer,” with expiry in 2041.
  • “We would like to thank the Australian Patent Office for this notification of intent, which further validates the potential of our new class of anti-infectives to help patients with a broad range of bacterial and viral infections,” said James Graham, Chief Executive Officer of Recce Pharmaceutical.
  • Viral infections that may be caused by a range of viruses, such as coated viruses (e.g., lipid-coated viruses), include herpes, human immunodeficiency virus (HIV), cytomegalovirus, and influenza.
  • Other examples include influenza A, Ross River virus, and coronaviruses, including those responsible for severe acute respiratory syndrome.

Sex Therapist Deb Laino Offers Tips in Response to Increased STD Rates Among Older Adults

Retrieved on: 
Thursday, March 30, 2023
Specialty, Public Policy, Government, Cosmetics, Retail, Other Transport, Teens, Parenting, Transport, Other Technology, Philanthropy, Other Education, LGBTQ+, Education, Search Engine Optimization, Search Engine Marketing, Other Manufacturing, Technology, Practice Management, Women, Other Philanthropy, Seniors, Managed Care, Other Science, Research, Discount, Variety, Men, Department Stores, Manufacturing, Family, Other Health, Consumer, Marketing, Advertising, Communications, Convenience Store, Health, Fund Raising, Foundation, Science, Other Policy Issues, Nursing, Other Retail, Vagina, HIV, Syphilis, Tears, Ageing, Gonorrhea, Woman, Statistics, Risk, STD, CDC, Somatosensory system, Lubricant, Korea Disease Control and Prevention Agency, Vertically transmitted infection, Chlamydia, Condom, Birth control

Sex therapist and expert Deb Laino says there are many factors contributing to the rise in STDs in older adults, including less people getting screened and using condoms, which are proven to prevent illnesses such as chlamydia and gonorrhea.

Key Points: 
  • Sex therapist and expert Deb Laino says there are many factors contributing to the rise in STDs in older adults, including less people getting screened and using condoms, which are proven to prevent illnesses such as chlamydia and gonorrhea.
  • In 2019, Syphilis cases increased by 23 percent among adults 55 and older.
  • Most recent statistics also revealed that adults aged 45-54 had the highest rates of chlamydia and gonorrhea compared to other age groups, and the rate of HIV diagnoses increased by 4 percent among adults aged 55-64 between 2015-2019.
  • Consider regular testing: It's generally recommended that sexually active adults get tested for STDs at least once a year, regardless of age.

Visby Medical™ Receives FDA Clearance and CLIA Waiver for Second Generation Sexual Health Test for Women

Retrieved on: 
Tuesday, March 14, 2023
SAN, Pharmacy, Patient, Korea Disease Control and Prevention Agency, Food, Visby, STI, Associate, Neisseria gonorrhoeae, PCR, Gonorrhea, Trichomonas vaginalis, Risk, Prevention, Polymerase chain reaction, Woman, Workflow, Education, Health, Chlamydia trachomatis, MD, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Diagnosis, CLIA, POC, Stanford University, Pelvic inflammatory disease, Pharmaceutical industry, Birth control, Operation, Medicine, Neisseria, Trichomonas, Chlamydia

The Visby Medical Sexual Health test is a fast, polymerase chain reaction (PCR) diagnostic test for the detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.

Key Points: 
  • The Visby Medical Sexual Health test is a fast, polymerase chain reaction (PCR) diagnostic test for the detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women.
  • The CLIA-waived, Sexual Health POC test provides accurate results in under 30 minutes, enabling clinicians to test, talk and accurately treat with confidence in a single patient visit.
  • "The Visby Sexual Health Test has been a game changer for us.
  • The Visby test is a win-win, helping fight antibiotic resistance as well as the spread of untreated infection, while empowering patients to engage health services with greater confidence."

binx health and the Elton John AIDS Foundation Aim to Break Down Barriers to PrEP and STI Screening Through Convenient binx everywhere At-home Solutions

Retrieved on: 
Tuesday, March 7, 2023
Organization, STI, Elton John AIDS Foundation, Chlamydia, Pre-exposure prophylaxis, Hepatitis B, Elton, Trichomoniasis, Geography, Gonorrhea, HIV, Hepatitis C, HIV/AIDS, HPV, Creatinine, Syphilis, Insurance, Infection, Pharmaceutical industry

“The Elton John AIDS Foundation and binx health have a shared commitment to make HIV testing and PrEP more accessible for those in greatest need,” said Anne Aslett, CEO of the Elton John AIDS Foundation.

Key Points: 
  • “The Elton John AIDS Foundation and binx health have a shared commitment to make HIV testing and PrEP more accessible for those in greatest need,” said Anne Aslett, CEO of the Elton John AIDS Foundation.
  • With binx health and the Elton John AIDS Foundation, now at-risk communities can receive care remotely and confidentially in a space of their choosing, without traveling to a clinic, and pick up their PrEP therapy where they wish, including binx partner pharmacies.
  • “We are especially proud to be supporting as esteemed an organization as the Elton John AIDS Foundation and look forward to working closely to help efforts in the battle against HIV/AIDS nationally.
  • Please visit ejaf.mybinxhealth.com to purchase individual kits or contact [email protected] for more information on bulk kits.

binx health and Birmingham AIDS Outreach Launch New Program to Improve Access to HIV and STI Testing Amid Surging Infection Rates

Retrieved on: 
Wednesday, March 1, 2023
Trichomoniasis, Infection, STD, Chlamydia, HIV, Market access, Partnership, HIV/AIDS, Syphilis, Patient, Health Oriented Preventive Education, Education, Sassy, AIDS, BAO, STI, Incidence, Gonorrhea, Birth control

BOSTON and BIRMINGHAM, Ala., March 01, 2023 (GLOBE NEWSWIRE) -- Birmingham AIDS Outreach (BAO), Alabama’s leading advocacy organization for people living with HIV/AIDS, and binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, launch the Sassy Little Box program to enable access to HIV and sexually transmitted infection (STI) testing and care at the community level. The Sassy Little Box program aims to serve at-risk communities throughout the greater Birmingham area and leverages years of partnership between BAO and the LGBTQ+ community, providing a coordinated community response to address disproportionately high HIV and STI incidence rates in Jefferson County, Alabama.

Key Points: 
  • The new Sassy Little Box program enhances BAO’s testing services by engaging patients through local partnerships to distribute HIV/STI self-collection kits to the community.
  • “BAO is always trying new and innovative ways to provide HIV and STD testing services in the community.
  • "We are honored to be working with BAO and the community-based partners involved in this novel screening program."
  • If you are an organization looking to learn more about a program that can increase access to care for your populations, please contact binx health at [email protected] .

Innoviva Reports Fourth Quarter 2022 Financial Results and Highlights Recent Company Progress

Retrieved on: 
Tuesday, February 28, 2023
Health, Infectious Diseases, Other Health, General Health, Pharmaceutical, Biotechnology, Infectious Diseases Society of America, PDUFA, Therapy, Zoliflodacin, GSK, Armata, Priority review, Partnership, Share repurchase, FDA, Investment, Abstract, Regulation of tobacco by the U.S. Food and Drug Administration, TRC, NDA, Infection, Tax, Sale, ABC, Gonorrhea, Food, Pension fund, Generic drug, Cryptocurrency, Pharmaceutical industry

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or “the Company”), a diversified holding company with a portfolio of royalties and other healthcare assets, today reported financial results for the fourth quarter ended December 31, 2022.

Key Points: 
  • Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or “the Company”), a diversified holding company with a portfolio of royalties and other healthcare assets, today reported financial results for the fourth quarter ended December 31, 2022.
  • Net cash and cash equivalents totaled $291.0 million, and royalty and product sale receivables totaled $64.1 million as of December 31, 2022.
  • RELVAR®/BREO® ELLIPTA® global net sales decreased in the fourth quarter of 2022 primarily due to unfavorable prior period adjustments in the U.S., despite stable volume trends.
  • Fourth quarter 2022 net sales of ANORO® ELLIPTA® by GSK were $159.8 million with $82.6 million net sales from the U.S. market and $77.2 million from non-U.S. markets.

Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors

Retrieved on: 
Tuesday, February 14, 2023
Hand, Physician, Hospital, Tetracycline, MDR, Ciprofloxacin, Ceftriaxone, Food and Drug Administration, Food, AMR, Cefixime, AST, FDA, Infection, Microbiology, Bacteria, Azithromycin, Gonorrhea, Antimalarial medication, NGP, Pharmaceutical industry, Vaccine

BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that healthcare industry veteran Jamie Condie has joined the company's Board of Directors.

Key Points: 
  • BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that healthcare industry veteran Jamie Condie has joined the company's Board of Directors.
  • "Selux has emerged as a clear leader in the global fight against antibiotic resistance by redefining the speed and performance of AST.
  • With FDA clearance in hand, Selux can now share its Next Generation Phenotyping technology with the industry to transform the treatment of infectious disease," said Condie.
  • As we bring the fastest AST platform with a future-proof antibiotic menu to bear on this problem, we are fortunate to have Jamie join Selux's Board of Directors," said Steve Lufkin, CEO of Selux.